We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

117 hedge funds and large institutions have $242M invested in Dynavax Technologies in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 50 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more call options, than puts

Call options by funds: $5.79M | Put options by funds: $1.24M

100% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 25

22.9% more ownership

Funds ownership: 80.93%103.83% (+23%)

15% more capital invested

Capital invested by funds: $210M → $242M (+$31.9M)

8% less funds holding

Funds holding: 127117 (-10)

43% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 21

Holders
117
Holders Change
-10
Holders Change %
-7.87%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
50
Reduced
25
Closed
21
Calls
$5.79M
Puts
$1.24M
Net Calls
+$4.55M
Net Calls Change
+$2.9M

DVAX Hedge Fund Activity: Q3 2019 in Review

117 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2019, worth a combined $242M — up 15% from $210M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of DVAX and 12 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 50 added.

The largest buyer was Bain Capital Life Sciences Investors, opening a new position worth an estimated $32.8M. The largest seller was Franklin Resources, cutting an estimated $8.12M.

  • 117 institutional investors held Dynavax Technologies (DVAX) as of Q3 2019, down from 127 in Q2 2019.
  • Funds reported $242M of Dynavax Technologies stock for Q3 2019, up 15% quarter-over-quarter.
  • 12 funds opened new Dynavax Technologies positions in Q3 2019 and 21 closed out, a net change of -9 holders.
  • The largest Dynavax Technologies buyer in Q3 2019 was Bain Capital Life Sciences Investors, an estimated $32.8M added.
  • The largest Dynavax Technologies seller in Q3 2019 was Franklin Resources, an estimated $8.12M sold.

Based on aggregated 13F filings for Q3 2019.